Medicare Enrolled
Dr. Anish Koka, MD
Cardiovascular Disease · Philadelphia, PA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Koka from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Koka?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Koka
Dr. Anish Koka is a cardiovascular disease specialist in Philadelphia, PA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Koka performed 5,604 Medicare services across 3,811 unique beneficiaries.
Between the years covered by Open Payments, Dr. Koka received a total of $37,273 from 44 pharmaceutical and/or device companies across 462 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Koka is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 5% volume in PA
$37,273 industry payments
Medicare Practice Summary
Medicare Utilization ↗5,604
Medicare services
Top 5% in PA for cardiovascular disease
3,811
Unique beneficiaries
$69
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~280 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
1,542 | $11 | $81 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,253 | $93 | $147 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
797 | $128 | $261 |
| EKG interpretation and report A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report. |
499 | $6 | $85 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
415 | $157 | $540 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
178 | $66 | $138 |
| Remote patient monitoring management, 20 min/month Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month. |
144 | $36 | $150 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
133 | $165 | $556 |
| Remote patient monitoring device, 30 days Initial setup of devices for remote monitoring of body functions with daily data transmission or alerts. This service covers the first 30 days of the monitoring period. |
126 | $37 | $190 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
120 | $41 | $100 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
115 | $98 | $285 |
| Smoking cessation counseling, 4-10 minutes A brief counseling session focused on helping patients quit smoking and tobacco use. The provider spends 4 to 10 minutes discussing strategies and support for cessation. |
83 | $15 | $30 |
| Remote cardiac rhythm monitor evaluation, up to 30 days Review and analysis of data from a remote cardiac rhythm monitoring system over a period of up to 30 days. |
76 | $17 | $100 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
51 | $54 | $204 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
30 | $370 | $800 |
| Technetium Tc-99m sestamibi diagnostic injection A diagnostic injection of technetium Tc-99m sestamibi used for imaging studies. |
30 | $125 | $300 |
| Continuous ECG monitoring, up to 30 days Continuous heart rhythm monitoring for up to 30 days, including professional review and reporting of the results. |
12 | $21 | $60 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
7.4% high complexity
6.5% medium
86.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$37,273
Total received (2018-2024)
Avg $5,325/year across 7 years
Top 11% in PA for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
44
Companies
462
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$23,474 (63.0%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,991 (26.8%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$3,808 (10.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,300
2023
$3,173
2022
$1,629
2021
$3,964
2020
$7,741
2019
$9,439
2018
$10,027
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Janssen Pharmaceuticals, Inc
$322
AstraZeneca Pharmaceuticals LP
$147
Amgen Inc.
$123
Novo Nordisk Inc
$100
Actelion Pharmaceuticals US, Inc.
$94
Boehringer Ingelheim Pharmaceuticals, Inc.
$91
Alnylam Pharmaceuticals Inc.
$69
Abbott Laboratories
$62
E.R. Squibb & Sons, L.L.C.
$46
PFIZER INC.
$33
Kiniksa Pharmaceuticals International, plc
$31
Boston Scientific Corporation
$29
HEARTFLOW, INC.
$25
Merck Sharp & Dohme LLC
$22
GlaxoSmithKline, LLC.
$21
Novartis Pharmaceuticals Corporation
$20
Esperion Therapeutics, Inc.
$18
Philips North America LLC
$18
iRhythm Technologies, Inc.
$15
GENZYME CORPORATION
$14
Top 3 companies account for 45.6% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$12,927
Boehringer Ingelheim Pharmaceuticals, Inc.
$10,473
Janssen Pharmaceuticals, Inc
$2,942
Amgen Inc.
$2,511
Lilly USA, LLC
$1,838
Medtronic, Inc.
$1,632
PFIZER INC.
$1,086
Novo Nordisk Inc
$618
Actelion Pharmaceuticals US, Inc.
$420
E.R. Squibb & Sons, L.L.C.
$336
Abbott Laboratories
$278
Merck Sharp & Dohme LLC
$232
SANOFI-AVENTIS U.S. LLC
$214
Onkos Surgical, Inc.
$183
Regeneron Healthcare Solutions, Inc.
$170
Novartis Pharmaceuticals Corporation
$162
Merck Sharp & Dohme Corporation
$138
BOSTON SCIENTIFIC CORPORATION
$134
Allergan Inc.
$94
Daiichi Sankyo Inc.
$84
Boston Scientific Corporation
$76
Alnylam Pharmaceuticals Inc.
$69
Janssen Biotech, Inc.
$63
PORTOLA PHARMACEUTICALS, LLC
$56
Esperion Therapeutics, Inc.
$52
Amarin Pharma Inc.
$41
Preventice Services, LLC
$39
iRhythm Technologies, Inc.
$38
GENZYME CORPORATION
$34
ATRICURE, INC.
$34
Kiniksa Pharmaceuticals International, plc
$31
PORTOLA PHARMACEUTICALS, INC.
$30
ARBOR PHARMACEUTICALS, INC.
$28
HEARTFLOW, INC.
$25
Lexicon Pharmaceuticals, Inc.
$24
Relypsa, Inc.
$24
Edwards Lifesciences Corporation
$21
GlaxoSmithKline, LLC.
$21
Kiniksa Pharmaceuticals, Ltd.
$19
ARRAY BIOPHARMA INC
$18
Philips North America LLC
$18
Genentech, Inc.
$15
SCPHARMACEUTICALS INC.
$15
ABBVIE INC.
$13
Top 3 companies account for 70.7% of all-time payments
Associated products mentioned in payments ›
(5044) MCOT · AMVUTTRA · ANDEXXA · Arcalyst · Assurity Pacemaker · BG Mini Plus · BRAFTOVI · BRILINTA · Bidil · CAMZYOS · CARDIOMEMS · CHANTIX · COBALT DR MRI SURESCAN · CardioMEMS HF System · Confirm Rx · Corlanor · EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) · ELEOS LIMB SALVAGE SYSTEM · ELIQUIS · ENTRESTO · EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX · Edarbi · FABRAZYME · FARXIGA · FFRct · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FUROSCIX · INJECTAFER · Inpefa · JARDIANCE · JOT DX · LEQVIO · LOKELMA · MULTAQ · NEXLETOL · ONPATTRO · OPSUMIT · Ozempic · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · RYBELSUS · Repatha · Rybelsus · S ICD · SHINGRIX · Saxenda · UPTRAVI · Unify Assura CRT Defibrillator · VENASEAL · VERQUVO · VRAYLAR · VYNDAMAX · VYNDAQEL · Vascepa · Veltassa · WAINUA · WATCHMAN · WATCHMAN FLX · Wegovy · XARELTO · Xofluza · ZIO Patch · Zio monitor
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (63%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in cardiovascular disease and does not inherently indicate bias, but patients may wish to be aware.
Geographic Context
Cardiologists within 10 mi
744
Per 100K population
47.0
County median income
$60,698
Nearest hospital
THOMAS JEFFERSON UNIVERSITY HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Koka is a clinical cardiology specialist, with above-average Medicare volume (top 5% in PA), with speaking/promotional industry engagement in the top 11% of PA peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Koka experienced with electrocardiogram (ekg), 12-lead?
Based on Medicare claims data, Dr. Koka performed 1,542 electrocardiogram (ekg), 12-lead services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Koka receive payments from pharmaceutical companies?
Yes. Dr. Koka received a total of $37,273 from 44 companies across 462 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Koka's costs compare to other cardiologists in Philadelphia?
Dr. Koka's average Medicare payment per service is $69. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Koka) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Philadelphia
Browse cardiologists in Philadelphia ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in PA
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in PA
Which PA cardiologists receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology